Skip to main content
Porto
  • Home
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

MMRF: New Drug Approval - What Does the Arrival of XPOVIO (selinexor) Mean for Multiple Myeloma Patients?

MMRF logoWhat: Webcast slides and audio (1:03:12)
When: Thursday October 17, 2019
Where: Web
Access slides

Tags
event
mmrf
archived
webcast
xpovio
selinexor
Dr. Paul Richardson
  • Read more about MMRF: New Drug Approval - What Does the Arrival of XPOVIO (selinexor) Mean for Multiple Myeloma Patients?

MMRF: Updates on New Drug Approvals and the Expanding Therapeutic Landscape in Multiple Myeloma

MMRF logoWhat:  Webcast
When: Tuesday, November 17, 2020 100 PM – 2:00 PM ET
Where: Web
View slides

Tags
event
archived
webcast
mmrf
treatment
newly approved drugs
blenrep
belantamab mafodotin
xpovio
selinexor
darzalex faspro
daratumumab and hyaluronidase
sarclisa
isatuximab
Dr. Joshua R. Richter
Dr. Nina Shah
  • Read more about MMRF: Updates on New Drug Approvals and the Expanding Therapeutic Landscape in Multiple Myeloma

Myeloma Crowd: Sharing Selinexor Stories

Myeloma Crowd logoWhat: Webcast
When: Wednesday April 28, 2021 1:00-2:00 PM ET
Where: Web

Tags
event
webcast
no archive
myeloma crowd
selinexor
xpovio
treatment
Beth Ayen
Audrey Burton-Bethke
  • Read more about Myeloma Crowd: Sharing Selinexor Stories

Myeloma Crowd: What Myeloma Specialists Have to Say about Selinexor

Myeloma Crowd logoWhat: Webcast
When: Wednesday November 24, 2021 1:00-2:00 PM ET
Where: Web
More Information & Register

Tags
event
webcast
no archive
myeloma crowd
treatment
selinexor
xpovio
Audrey Burton-Bethke
Patricia Flores
  • Read more about Myeloma Crowd: What Myeloma Specialists Have to Say about Selinexor
Subscribe to xpovio